Replimune Group Inc.

NASDAQ: REPL · Real-Time Price · USD
5.71
-0.08 (-1.38%)
At close: Sep 17, 2025, 3:59 PM
5.68
-0.53%
Pre-market: Sep 18, 2025, 08:39 AM EDT
-1.38%
Bid 5.65
Market Cap 445.7M
Revenue (ttm) 1.47M
Net Income (ttm) -280.22M
EPS (ttm) -3.24
PE Ratio (ttm) -1.76
Forward PE -1.94
Analyst Hold
Dividends n/a
Ask 6
Volume 2,222,743
Avg. Volume (20D) 9,292,038
Open 5.79
Previous Close 5.79
Day's Range 5.70 - 5.93
52-Week Range 2.68 - 17.00
Beta 0.51
Ex-Dividend Date n/a

About REPL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol REPL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for REPL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
Replimune Group Inc. is scheduled to release its earnings on Nov 11, 2025, before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+10.68%
Replimune shares are trading higher, reversing aft... Unlock content with Pro Subscription
1 month ago
+101.33%
Shares of several biotechnology stocks are trading higher amid Vinay Prasad's departure as director of the FDA's Center for Biologics Evaluation and Research.